Načítá se...
Reversal of Dabigatran with Idarucizumab in Acute Subarachnoid Hemorrhage
Dabigatran etexilate mesylate is a direct thrombin inhibitor used for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Dabigatran belongs to a new generation of oral agents for anticoagulation – the direct oral anticoagulants (DOACs). The DOACs als...
Uloženo v:
| Vydáno v: | Clin Pract Cases Emerg Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5965212/ https://ncbi.nlm.nih.gov/pubmed/29849330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5811/cpcem.2017.6.34356 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|